MENLO PARK, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the ...
MENLO PARK, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the ...
Oruka Therapeutics, Inc. (ORKA) announced an update on their ongoing clinical study. Study Overview Oruka Therapeutics, Inc. is running a Phase 2 trial called “A Multicenter, Randomized, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback